Here's Why Vivos Therapeutics, Inc. (VVOS) Could be Great Choice for a Bottom FisherZacks Investment Research • 08/23/23
Vivos Therapeutics Reports Second Quarter 2023 Financial Results and Provides Operational UpdateGlobeNewsWire • 08/16/23
Vivos Therapeutics Reschedules Second Quarter 2023 Financial Results Conference CallGlobeNewsWire • 08/16/23
Vivos Therapeutics to Reschedule Second Quarter 2023 Financial Results Conference CallGlobeNewsWire • 08/14/23
Vivos Therapeutics Schedules Release of Second Quarter 2023 Financial Results and Conference CallGlobeNewsWire • 08/11/23
Looking for a Fast-paced Momentum Stock at a Bargain? Consider Vivos Therapeutics, Inc. (VVOS)Zacks Investment Research • 06/13/23
Vivos Therapeutics, Inc. (VVOS) Reports Q1 Loss, Tops Revenue EstimatesZacks Investment Research • 06/08/23
Vivos Therapeutics Reports First Quarter 2023 Financial Results and Provides Operational UpdateGlobeNewsWire • 06/08/23
Vivos Therapeutics Schedules Release of First Quarter 2023 Financial Results and Conference CallGlobeNewsWire • 06/06/23
Vivos Therapeutics expects to reach positive cash flow a full quarter earlier thanks to new initiativesProactive Investors • 05/09/23
Vivos Therapeutics reports positive results from migraine study; shares skyrocketProactive Investors • 05/01/23
Clinical Study Shows 92% of Patients Report Resolution of Migraine Headaches Using Vivos' POD® Appliance TreatmentGlobeNewsWire • 05/01/23
Vivos Therapeutics says 2022 and early 2023 accomplishments sets stage for potential revenue growth this yearProactive Investors • 03/30/23
Vivos Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Operational UpdateGlobeNewsWire • 03/30/23
Vivos Therapeutics Schedules Release of Fourth Quarter and Full Year 2022 Financial Results and Conference CallGlobeNewsWire • 03/30/23
Vivos Therapeutics to Participate in Fireside Chat at the 35th Annual ROTH ConferenceGlobeNewsWire • 03/08/23
Vivos Therapeutics Expands Product Line and Revenue Potential with Acquisition of Product Rights and Patents from Advanced Facialdontics, LLCGlobeNewsWire • 03/01/23
Vivos Therapeutics to Present at the Emerging Growth Conference on February 22, 2023GlobeNewsWire • 02/21/23